Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.
about
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Can EGFR-Tyrosine Kinase Inhib ...... (MPE) in Lung Adenocarcinoma.
@en
Can EGFR-Tyrosine Kinase Inhibitors
@nl
type
label
Can EGFR-Tyrosine Kinase Inhib ...... (MPE) in Lung Adenocarcinoma.
@en
Can EGFR-Tyrosine Kinase Inhibitors
@nl
prefLabel
Can EGFR-Tyrosine Kinase Inhib ...... (MPE) in Lung Adenocarcinoma.
@en
Can EGFR-Tyrosine Kinase Inhibitors
@nl
P2093
P2860
P1476
Can EGFR-Tyrosine Kinase Inhib ...... n (MPE) in Lung Adenocarcinoma
@en
P2093
Akash Verma
Akhil Chopra
Albert Y H Lim
Atasha B Asmat
Dokeu B A Aneez
Fazuludeen A Akbar
Lavina D Bharwani
Sanjay H Chotirmall
P2860
P356
10.2174/1570163813666160524142846
P577
2016-01-01T00:00:00Z